S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

AKTX Akari Therapeutics PLC

1.17

-0.23 (-16.43%)

Apr 29 2025 - Closed

Delayed by 15 minutes

Form 424B3 - Prospectus [Rule 424(b)(3)]

Article too big to display. Click here to view on the SEC website

Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
From Mar 2025 to Apr 2025

Click Here for more Akari Therapeutics Charts.

Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
From Apr 2024 to Apr 2025

Click Here for more Akari Therapeutics Charts.

Akari Therapeutics PLC News

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 29 April 2025 (8 hours ago) • Edgar (US Regulatory)

Akari Therapeutics Releases Welcome Video from Newly Appointed Chief Executive Officer, Abizer Gaslightwala
Tuesday 22 April 2025 (1 week ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 16 April 2025 (2 weeks ago) • Edgar (US Regulatory)

Akari Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
Wednesday 16 April 2025 (2 weeks ago) • GlobeNewswire Inc.

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Monday 31 March 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 24 March 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 24 March 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 24 March 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 24 March 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 24 March 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 24 March 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 24 March 2025 (1 month ago) • Edgar (US Regulatory)

More Akari Therapeutics PLC News Articles

NioCorp Developments

Mullen Automotive

CyberFuels (PK)

Therapeutic Solutions (PK)

Enzolytics (PK)

North Bay Resources (PK)

Liquidmetal Technologies (QB)

Movement Industries (PK)

Asia Broadband (PK)

Elite Pharmaceuticals (QB)

Odyssey Marine Exploration

Clean Vision (QB)

MineralRite (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions